Key statistics
On Wednesday, Catalyst Pharmaceuticals Inc (CN2:STU) closed at 20.18, -15.99% below its 52-week high of 24.02, set on Mar 25, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 20.10 |
|---|---|
| High | 20.38 |
| Low | 19.63 |
| Bid | 20.15 |
| Offer | 20.20 |
| Previous close | 20.36 |
| Average volume | 8.00 |
|---|---|
| Shares outstanding | 122.91m |
| Free float | 115.36m |
| P/E (TTM) | 14.16 |
| Market cap | 2.98bn USD |
| EPS (TTM) | 1.71 USD |
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Announcements
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
- Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
- Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
- Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
- Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
- Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
More ▼
